Lumos Diagnostics Holdings Limited

ASX (AUD): Lumos Diagnostics Holdings Limited (LDX)

Last Price

0.036

Today's Change

0.00 (0.00%)

Day's Change

0.036 - 0.036

Trading Volume

822,392

Profile
LDX

Exchange:  Australian Securities Exchange Australian Securities Exchange

Currency:  AUD AUD

Sector:  Healthcare - Healthcare Healthcare - Healthcare

Industry: 

CEO:  Mr. Douglas Ward Mr. Douglas Ward

Full Time Employees:  0 0

IPO Date:  2021-07-05 2021-07-05

CIK: 

ISIN:  AU0000157091 AU0000157091

CUSIP: 

Beta:  0.78 0.78

Last Dividend:  0.00 0.00

Dcf Diff:  0.00 0.00

Dcf:  0.00 0.00

Description

Lumos Diagnostics Holdings Limited, a contract research and development company, develops and commercializes rapid point-of-care (POC) diagnostic tests which are primarily focuses on the diagnosis and management of infectious diseases in the United States and Australia. The company products include FebriDx, a POC diagnostic test for detecting and differentiating viral and bacterial respiratory infections; ViraDx, a three-in-one POC test for influenza A, influenza B, and COVID-19.; and CoviDx, a rapid antigen test for COVID-19. It also offers desktop readers, disposable readers, and Lumos Leelu readers. Lumos Diagnostics Holdings Limited was founded in 2004 and is based in Melbourne, Australia.

Address

Level 4,
Melbourne, VIC 3205, AU

61 3 9087 1598

http://lumosdiagnostics.com

Discussions
Be the first to like this. Showing 0 of 0 comments
Post a Comment